Status:
COMPLETED
Effect of Bra Use During Radiotherapy for Breast Cancer Radiotherapy
Lead Sponsor:
Yonsei University
Conditions:
Breast Cancer
Radiation Therapy
Eligibility:
FEMALE
Phase:
NA
Brief Summary
This prospective randomized study investigated the reproducibility of breast shape, radiation dose irradiated to the lungs, heart, dose distribution, patient satisfaction, and treatment toxicity when ...
Detailed Description
Post-surgery radiotherapy to the breast is standard treatment after breast-conserving surgery in patients with breast cancer. In order to apply the latest radiation therapy technologies, such as inten...
Eligibility Criteria
Inclusion
- Patients with histologically confirmed invasive breast cancer or ductal carcinoma in situ
- Patients eligible for whole breast irradiation after partial mastectomy
- Adults over 20 years old
- Patients with good overall performance (ECOG PS 0-1)
Exclusion
- Recurrent breast cancer patients
- Patients who have previously received radiation therapy to the ipsilateral breast
- Patients who underwent breast reconstruction
- Bilateral breast cancer
- Patients with skin diseases such as contact dermatitis
Key Trial Info
Start Date :
December 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 20 2024
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT06178861
Start Date
December 1 2022
End Date
October 20 2024
Last Update
February 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yongin Severance Hospital
Yongin-si, South Korea, 365